PMD stock forecast
Our latest prediction for Psychemedics Corp.'s stock price was made on the June 14, 2019 when the stock price was at 9.98$.
In the short term (2weeks), PMD's stock price should outperform the market by 2.16%. During that period the price should oscillate between -5.67% and +7.64%.
In the medium term (3months), PMD's stock price should outperform the market by 2.14%. During that period the price should oscillate between -13.17% and +20.57%.Get email alerts
About Psychemedics Corp.
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.
At the moment the company generates 42M USD in revenues.
On its last earning announcement, the company reported a profit of 0.71$ per share.
The book value per share is 3.32$
Three months stock forecastJune 14, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|